PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.\', \'Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.\', \'St Vincent\'s Clinical School, University of New South Wales, Sydney, NSW, Australia.\', \'School of Medical Sciences, Women\'s & Children\'s, and School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.\', \'Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia. t.mercer@uq.edu.au.\', \'Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Brisbane, QLD, Australia. t.mercer@uq.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-81760-0
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33514761
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all